Akero Therapeutics (AKRO) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free AKRO Stock Alerts $20.69 -0.31 (-1.48%) (As of 11:06 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Akero Therapeutics Short Interest DataCurrent Short Volume7,840,000 sharesPrevious Short Volume9,470,000 sharesChange Vs. Previous Month-17.21%Dollar Volume Sold Short$198.04 millionShort Interest Ratio / Days to Cover5.8Last Record DateMarch 31, 2024Outstanding Shares69,150,000 sharesPercentage of Shares Shorted11.34%Today's Trading Volume84,002 sharesAverage Trading Volume1,244,026 sharesToday's Volume Vs. Average7% Short Selling Akero Therapeutics ? Sign up to receive the latest short interest report for Akero Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAKRO Short Interest Over TimeAKRO Days to Cover Over TimeAKRO Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Akero Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,840,000 shares $198.04 million -17.2%N/A5.8 $25.26 3/15/20249,470,000 shares $260.80 million +0.7%N/A6.9 $27.54 2/29/20249,400,000 shares $253.71 million +5.7%N/A6.9 $26.99 2/15/20248,890,000 shares $190.33 million +14.6%N/A8.2 $21.41 1/31/20247,760,000 shares $167.69 million +2.1%N/A7.2 $21.61 1/15/20247,600,000 shares $170.54 million +3.1%N/A6.3 $22.44 Get the Latest News and Ratings for AKRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20237,370,000 shares $172.09 million +12.4%N/A3.8 $23.35 12/15/20236,560,000 shares $150.29 million +3.0%N/A3.4 $22.91 11/30/20236,370,000 shares $106.63 million +3.6%N/A3.4 $16.74 11/15/20236,150,000 shares $90.10 million +4.4%N/A3.3 $14.65 10/31/20235,890,000 shares $70.21 million -3.6%N/A3.3 $11.92 10/15/20236,110,000 shares $89.39 million +5.7%N/A3.8 $14.63 9/30/20235,780,000 shares $292.35 million -3.5%N/A4.7 $50.58 9/15/20235,990,000 shares $312.92 million -5.4%N/A8.2 $52.24 8/31/20236,330,000 shares $314.16 million +8.0%N/A9.3 $49.63 8/15/20235,860,000 shares $278.17 million +1.7%N/A8.9 $47.47 7/31/20235,760,000 shares $249.98 million +5.1%N/A8.6 $43.40 7/15/20235,480,000 shares $249.72 million +14.4%N/A8 $45.57 6/30/20234,790,000 shares $223.65 million +6.2%N/A6.7 $46.69 6/15/20234,510,000 shares $249.00 million -3.8%N/A6.2 $55.21 5/31/20234,690,000 shares $209.08 million +0.9%N/A6.8 $44.58 5/15/20234,650,000 shares $221.85 million No ChangeN/A7 $47.71 4/30/20234,650,000 shares $208.04 million -2.7%N/A7.5 $44.74 4/15/20234,780,000 shares $181.59 million +8.1%N/A7.8 $37.99 3/31/20234,420,000 shares $169.11 million +30.8%N/A7.4 $38.26 3/15/20233,380,000 shares $136.92 million -0.9%N/A5.2 $40.51 2/28/20233,410,000 shares $155.19 million -5.0%N/A4.7 $45.51 2/15/20233,590,000 shares $161.55 million -5.8%N/A4.9 $45.00 1/31/20233,810,000 shares $188.60 million -8.9%N/A5 $49.50 1/15/20234,180,000 shares $210.00 million -20.5%N/A5.5 $50.24 12/30/20225,260,000 shares $288.25 million +27.7%N/A6.9 $54.80 12/15/20224,120,000 shares $181.57 million -16.8%N/A5.2 $44.07 11/30/20224,950,000 shares $230.18 million +21.6%N/A3.2 $46.50 11/15/20224,070,000 shares $182.25 million -12.5%N/A2.7 $44.78 10/31/20224,650,000 shares $196.51 million +17.1%13.5%3.2 $42.26 10/15/20223,970,000 shares $152.85 million -24.7%11.8%2.8 $38.50 9/30/20225,270,000 shares $179.44 million -3.7%17.1%3.8 $34.05 9/15/20225,470,000 shares $145.12 million -11.5%17.8%4.3 $26.53 8/31/20226,180,000 shares $72.62 million +6.6%26.5%15.6 $11.75 8/15/20225,800,000 shares $75.23 million +4.9%24.8%15.9 $12.97Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. AKRO Short Interest - Frequently Asked Questions What is Akero Therapeutics' current short interest? Short interest is the volume of Akero Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 7,840,000 shares of AKRO short. Learn More on Akero Therapeutics' current short interest. What is a good short interest ratio for Akero Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKRO shares currently have a short interest ratio of 6.0. Learn More on Akero Therapeutics's short interest ratio. Which institutional investors are shorting Akero Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akero Therapeutics: Kingdon Capital Management L.L.C., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Akero Therapeutics' short interest increasing or decreasing? Akero Therapeutics saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 7,840,000 shares, a drop of 17.2% from the previous total of 9,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Akero Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Akero Therapeutics: Day One Biopharmaceuticals, Inc. (15.24%), Edgewise Therapeutics, Inc. (9.11%), Morphic Holding, Inc. (11.79%), Kura Oncology, Inc. (16.38%), Ardelyx, Inc. (15.05%), Arcus Biosciences, Inc. (17.43%), Zai Lab Limited (3.90%), ANI Pharmaceuticals, Inc. (0.93%), Gyre Therapeutics, Inc. (0.87%), Dynavax Technologies Co. (13.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Akero Therapeutics stock? Short selling AKRO is an investing strategy that aims to generate trading profit from Akero Therapeutics as its price is falling. AKRO shares are trading down $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akero Therapeutics? A short squeeze for Akero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKRO, which in turn drives the price of the stock up even further. How often is Akero Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKRO, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: DAWN Short Squeeze EWTX Short Squeeze MORF Short Squeeze KURA Short Squeeze ARDX Short Squeeze RCUS Short Squeeze ZLAB Short Squeeze ANIP Short Squeeze GYRE Short Squeeze DVAX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKRO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingNew Trump BombshellThe Freeport Society